Molecular predictors and immunomodulatory role of dual checkpoint inhibitor blockade using ipilimumab/nivolumab in patients with extensive stage small cell lung cancer

被引：0
|
作者：
Chiang, Anne C.
Asghari, Hossein
Ashley, Kerryan
Gettinger, Scott N.
Goldberg, Sarah B.
Herbst, Roy S.
Wilson, Frederick Hugh
Newton, Benjamin Robert
Cohenuram, Michael Keith
Sabbath, Kert D.
Talsania, Ashita D.
Russo, Armand Vincent
Schultz, Eric
Skrzypczak, Stan
Kingsford, Carl
Schalper, Kurt A.
机构：
[1] Yale Univ, Sch Med, New Haven, CT USA
[2] Ocean Genom, Pittsburgh, PA USA
[3] Yale Univ, Dept Pathol, New Haven, CT USA
[4] Yale Sch Med, New Haven, CT USA
[5] Yale Canc Ctr, New Haven, CT USA
[6] Smilow Canc Hosp Yale New Haven, Yale Sch Medicinel, Yale Canc Ctr, New Haven, CT USA
[7] Yale Univ, New Haven, CT USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2023年 / 41卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
8597
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Retreatment with nivolumab and ipilimumab with or without chemotherapy in patients with metastatic non-small cell lung cancer after progression on immune checkpoint inhibitor therapy
    Mederos, Nuria
    Bouchaab, Hasna
    Veillard, Jennifer
    Tu Nguyen-Ngoc
    Doumenc, Thibault
    Michielin, Olivier
    Pradervand, Sylvain
    Wicky, Alexandre M.
    Cuendet, Michel
    Peters, Solange
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [2] Immune checkpoint inhibitors in extensive-stage small cell lung cancer
    Zhang, Tongmei
    JOURNAL OF THE NATIONAL CANCER CENTER, 2022, 2 (03): : 130 - 131
  • [3] Longitudinal Tumor Microenvironment Analysis in Extensive Stage SCLC Patients Treated with Dual Checkpoint Inhibitor Blockade
    Chiang, A.
    Matera, R.
    Ashley, K.
    Rajendran, B. K.
    Schalper, K. A.
    JOURNAL OF THORACIC ONCOLOGY, 2024, 19 (10) : S362 - S362
  • [4] Association of antibiotic exposure with survival in patients with extensive-stage small cell lung cancer receiving immune checkpoint inhibitor therapy
    Zhong, Jiaqi
    Xiong, Dali
    Liu, Yu
    Yuan, Shuanghu
    THORACIC CANCER, 2024, 15 (02) : 152 - 162
  • [5] Early ctDNA Changes and Clinical Outcomes in Extensive Stage Small Cell Lung Cancer Patients on Nivolumab and Temozolomide
    Gheeya, J. S.
    Wei, L.
    Bucheit, L.
    Pilcher, C.
    Sukrithan, V.
    Konda, B.
    Ferguson, S.
    Jukich, M.
    Savardekar, H.
    Schwarz, E.
    Norman, R.
    Wesolowski, R.
    Jarson, W., III
    Kaufman, J.
    Alahmadi, A.
    Memmott, R.
    Shields, P.
    He, K.
    Bertino, E.
    Presley, C.
    Carbone, D. P.
    Verschraegen, C.
    Otterson, G. A.
    Owen, D.
    JOURNAL OF THORACIC ONCOLOGY, 2023, 18 (11) : S700 - S701
  • [6] Nivolumab and Ipilimumab as Maintenance Therapy in Extensive-Disease Small-Cell Lung Cancer: CheckMate 451
    Owonikoko, Taofeek K.
    Park, Keunchil
    Govindan, Ramaswamy
    Ready, Neal
    Reck, Martin
    Peters, Solange
    Dakhil, Shaker R.
    Navarro, Alejandro
    Rodriguez-Cid, Jeronimo
    Schenker, Michael
    Lee, Jong-Seok
    Gutierrez, Vanesa
    Percent, Ivor
    Morgensztern, Daniel
    Barrios, Carlos H.
    Greillier, Laurent
    Baka, Sofia
    Patel, Miten
    Lin, Wen Hong
    Selvaggi, Giovanni
    Baudelet, Christine
    Baden, Jonathan
    Pandya, Dimple
    Doshi, Parul
    Kim, Hye Ryun
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (12) : 1349 - +
  • [7] SMALL CELL LUNG CANCER MOLECULAR SUBTYPES AND VULNERABILITY TO IMMUNE CHECKPOINT BLOCKADE
    Nabet, Barzin
    Hamidi, Habib
    Banchereau, Romain
    Morris, Stefanie
    Adler, Leah
    Srivastava, Minu
    Patil, Namrata
    Gay, Carl
    Minna, John
    Heymach, John
    Chan, Joseph
    Rudin, Charles
    Byers, Lauren
    Liu, Stephen
    Reck, Martin
    Shames, David
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2022, 10 : A549 - A549
  • [8] A pilot study of ipilimumab and nivolumab in recurrent extensive-stage small cell lung cancer after platinum-based chemotherapy.
    Chiang, Anne C.
    Austin, Matthew
    Stewart, Tyler F.
    Arammash, Mohammad
    Bhatt, Sunil
    Gettinger, Scott N.
    Goldberg, Sarah B.
    Wilson, Frederick Hugh
    Newton, Benjamin Robert
    Cohenuram, Michael Keith
    Sabbath, Kert D.
    Talsania, Ashita D.
    Russo, Armand Vincent
    Herbst, Roy S.
    Schalper, Kurt A.
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [9] A prospective observational study of immune checkpoint inhibitor nivolumab treatment in patients with non-small cell lung cancer
    Fukui, T.
    Nakahara, Y.
    Otani, S.
    Katagiri, M.
    Mitsufuji, H.
    Kubota, M.
    Hiyoshi, Y.
    Ishihara, M.
    Kasajima, M.
    Igawa, S.
    Sasaki, J.
    ANNALS OF ONCOLOGY, 2017, 28 : 135 - 135
  • [10] Immune checkpoint inhibitors: a new landscape for extensive stage small cell lung cancer treatment
    Bianco, Andrea
    D'Agnano, Vito
    Matera, Maria Gabriella
    Della Gravara, Luigi
    Perrotta, Fabio
    Rocco, Danilo
    EXPERT REVIEW OF RESPIRATORY MEDICINE, 2021, 15 (11) : 1415 - 1425
12345